Patents/Inventors

H. Michael Shepard

Eugene, ORUS25 patents

19 Patents

US126009592026
PH20 Polypeptide Variants, Formulations and Uses Thereof
Halozyme, Inc.
0 cites
US124722662025
Antibodies and Enonomers
Enosi Therapeutics Corporation
0 cites
US123716852025
PH20 Polypeptide Variants with a Modification at Position 324 of the PH20 Polypeptide and a Method of Making Thereof
HALOZYME, Inc.
0 cites
US122643452025
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US121957732025
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US121522622024
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US121230352024
PH20 Polypeptide Variants, Formulations and Uses Thereof
Halozyme, Inc.
0 cites
US121105202024
PH20 Polypeptide Variants, Formulations and Uses Thereof
Halozyme, Inc.
0 cites
US121041842024
PH20 Polypeptide Variants, Formulations and Uses Thereof
Halozyme, Inc.
0 cites
US121041852024
PH20 Polypeptide Variants, Formulations and Uses Thereof
Halozyme, Inc.
0 cites
US120916922024
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US120777912024
PH20 Polypeptide Variants with a Modification at Position 309 of the PH20 Polypeptide and a Method of Making Thereof
HALOZYME, Inc.
0 cites
US120605902024
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US120547582024
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US120496522024
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US120376182024
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US120182982024
PH20 Polypeptide Variants, Formulations and Uses Thereof
HALOZYME, Inc.
0 cites
US119526002024
PH20 Polypeptide Variants, Formulations and Uses Thereof
Halozyme, Inc.
0 cites
US115849232023
Compositions of Adenosine Deaminase-2 (ADA2), Variants Thereof and Methods of Using Same
Halozyme, Inc.
0 cites